Site Search
Displaying results 101 - 110 of 573
Resource | Publications,
AVAC's 2018 annual state of the field report, No Prevention, No End! looks at today's prevention crisis and offers context, analysis and strategy to turn that crisis around.
Resource | Publications,
Nearly a quarter of the world’s new HCV infections occur among people who inject drugs (PWID): lack of access to sterile needles, syringes and other injection equipment renders them highly vulnerable to HCV. Legal and structural barriers also greatly increase HCV risk among PWID. Worldwide, more than 50% of the 15.6 million PWID are HCV antibody positive. Without urgent, strategic and measurable action that includes PWID, HCV will continue to inflict a staggering, and increasing, burden of preventable illness and death among families, communities and countries.
Resource | Guidelines,
Start Free, Stay Free, AIDS Free is a collaborative framework to accelerate the end of the AIDS epidemic among children, adolescents and young women by 2020.
Every child and adolescent living with HIV should have access to antiretroviral therapy (ART). The AIDS Free component of the framework has the specific goal of ensuring 95% of all children and adolescents living with HIV have access to lifelong ART by the end of 2018. These efforts will need to be sustained until 2020, when it is estimated that treating 95% of all children and adolescents living with HIV will require providing ART to 1.4 million children (aged 0-14). and 1 million adolescents (aged 15-19).
Resource | Tools,
In the past decade, national programmes and donor-funded projects have made great progress in reaching people living with HIV with life-saving treatment in countries across the globe. Measuring success of these initiatives requires strong monitoring and evaluation systems that produce high-quality data.
Efforts to ensure data quality, therefore, are not singular events occurring randomly. Rather, these processes need to become institutionalized as part of all routine data management processes.
The aim of this tool is to help countries that are planning to undertake rapid and robust data quality assessment (DQA) of national and partner data quality with a particular emphasis on HIV treatment while improving and supporting patient monitoring systems to improve data quality and use.
Resource | Publications,
Every child should be given the best chance to start life healthy and free from preventable diseases. Mother-to-Child transmission to HIV, hepatitis B and syphilis can be effectively prevented by immunization, and screening and treatment of pregnant woman.
The Regional Framework for the Triple Elimination of Mother-to-Child Transmission of HIV, Hepatitis B and Syphilis in Asia and the Pacific 2018-2030 suggests a coordinated approach to delivering these interventions using the shared maternal, newborn and child health platform to achieve elimination.
Resource | Publications,
Quezon City, (population 2.9 million, 2015) the most populous city in the country, has been at the forefront of the response. In 2015 to 2016, over 1500 new cases of HIV were diagnosed, approximately 10% of all cases in the country, while its population comprises less than three percent of the total Philippine population of 103 million.
Resource | Laws and Policies,
Antiretroviral treatment (ART) optimization is a key pillar in the AIDS Free agenda to reach the goal of ensuring 95% of all infants and children have access to lifesaving treatment.
This policy brief outlines key considerations to facilitate effective transition to more clinically appropriate regimens as optimal ARV medicines and dosage forms become available.
Resource | Tools,
The toolkit was developed under the umbrella of the Global Accelerator for Paediatric Formulations initiative to address some of the remaining challenges in developing HIV drugs for children and to serve as a global standard for accelerating high-quality research and development in this field. It provides an opportunity to capitalize on best practices and to set standards that enable drugs and formulations to be developed and introduced more rapidly.
The aim of this toolkit is to facilitate faster, more efficient and focused development of new formulations for the effective treatment of infants, children and adolescents living with HIV by synthesizing key considerations for different stages of the drug development process.